Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
2.320
+0.070 (3.11%)
At close: Oct 6, 2025, 4:00 PM EDT
2.300
-0.020 (-0.86%)
After-hours: Oct 6, 2025, 7:00 PM EDT
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $16.57 million as of October 6, 2025. Its market cap has increased by 35.24% in one year.
Market Cap
16.57M
Enterprise Value
17.22M
1-Year Change
35.24%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $16.57M, a decrease of -96.01%. That is a compound annual growth rate of -37.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 16.57M | 5.53% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |